NCT04394962

Brief Summary

The study will examine the effect of exposure to virtual reality on stress levels and pregnancy rates, in infertile women undergoing in vitro fertilization embryo transfer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
350

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 31, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 20, 2020

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

March 7, 2024

Status Verified

March 1, 2024

Enrollment Period

4.2 years

First QC Date

May 6, 2020

Last Update Submit

March 5, 2024

Conditions

Keywords

Virtual realityIn vitro fertilizationEmbryo transfer

Outcome Measures

Primary Outcomes (1)

  • Clinical pregnancy rate (CPR)

    The difference in CPR (determined by sonographic evidence of a gestational sac and fetal heart rate at 6 weeks' gestation by transvaginal ultrasound) between the study and the control group. An increase of 15% in the clinical pregnancy rate in the study group will be considered as significant.

    Assessed 4 weeks after ET (= 6 weeks of gestation)

Secondary Outcomes (3)

  • Stress levels - STAI questionnaires

    Questionnaires will be filled out in 3 different time points during the study: 1) Day 1 of recruitment, before beginning the medications for endometrial preparation 2) ET day, 30-60 minutes before ET 3) ET day, 5-10 minutes after ET procedure

  • Salivary alpha amylase (SAA) levels

    Samples will be collected in 3 different time points during the study: 1) Day 1 of recruitment, before beginning the medications for endometrial preparation 2) ET day, 30-60 minutes before ET 3) ET day, 5-10 minutes after ET procedure

  • Sympathetic autonomous nervous system expressions

    Measurements will be taken in 3 different time points during the study: 1) Day 1 of recruitment, before beginning the medications for endometrial preparation 2) 30-60 minutes before ET 3) ET day, 5-10 minutes after ET procedure

Study Arms (2)

Control group

NO INTERVENTION

Patients who will be randomized to the control group will be waiting for the ET procedure without any intervention and without any deviation from the standard of care

Study group

EXPERIMENTAL

Exposure to virtual reality environment exposure

Device: Virtual reality

Interventions

Patients randomized to the study group, will be provided with the VR headset and sensors. The VR exposure will take place before the ET procedure, during their routine pre-transfer waiting period, in a private room. The patient will be able to choose between three different calming VR environments (3 scenes: beach sunset, palm tree patio or redwood forest) and will be exposed to the chosen VR environment for a continuous duration of 15-30 minutes. The VR exposure will be passive, and the patient can control her observation inside the environment by herself, simply by moving her head. During this period, at any time and for any reason, the patient can discontinue the use of the VR session simply by self-removing the helmet

Also known as: "Oculus Rift" system, Immersive environment
Study group

Eligibility Criteria

Age21 Years - 54 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • year-old female patients, if using own ovum. Patients above this age range may be approached for study if using a donated ovum, as long as "egg age" (age of donor at ovum pick up) falls in 21-45 age range.
  • Undergoing frozen ET procedures, and approached for study on "Day 2 - Day 4" of ET transfer cycle.
  • Ability to provide written consent to use VR technology before the ET procedure

You may not qualify if:

  • Contraindication to use VR technology (Epilepsy/previous seizure, claustrophobia, current migraine, heart disease, visual and/or auditory deficits/use of medical devices such as cardiac pacemaker or hearing aids)
  • Anxiety disorder and/or Regular use of anti-anxiety medications
  • Major uterine anomalies and/or uterine fibroids distorting the cavity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Create Fertility Centre

Toronto, Ontario, M5G 1N8, Canada

Location

Related Publications (32)

  • Sunderam S, Kissin DM, Crawford SB, Folger SG, Boulet SL, Warner L, Barfield WD. Assisted Reproductive Technology Surveillance - United States, 2015. MMWR Surveill Summ. 2018 Feb 16;67(3):1-28. doi: 10.15585/mmwr.ss6703a1.

    PMID: 29447147BACKGROUND
  • Porat-Katz A, Eldar-Geva T, Kahane A, Laufer N, Younis JS, Radin O, Paltiel O. Use of complementary medical therapies by Israeli patients undergoing in vitro fertilization. Int J Gynaecol Obstet. 2015 May;129(2):133-7. doi: 10.1016/j.ijgo.2014.11.021. Epub 2015 Feb 7.

    PMID: 25687239BACKGROUND
  • Verhaak CM, Smeenk JM, Evers AW, Kremer JA, Kraaimaat FW, Braat DD. Women's emotional adjustment to IVF: a systematic review of 25 years of research. Hum Reprod Update. 2007 Jan-Feb;13(1):27-36. doi: 10.1093/humupd/dml040. Epub 2006 Aug 29.

    PMID: 16940360BACKGROUND
  • Yong P, Martin C, Thong J. A comparison of psychological functioning in women at different stages of in vitro fertilization treatment using the mean affect adjective check list. J Assist Reprod Genet. 2000 Nov;17(10):553-6. doi: 10.1023/a:1026429712794.

    PMID: 11209535BACKGROUND
  • Kondoh E, Okamoto T, Higuchi T, Tatsumi K, Baba T, Murphy SK, Takakura K, Konishi I, Fujii S. Stress affects uterine receptivity through an ovarian-independent pathway. Hum Reprod. 2009 Apr;24(4):945-53. doi: 10.1093/humrep/den461. Epub 2008 Dec 20.

    PMID: 19098291BACKGROUND
  • Levitas E, Parmet A, Lunenfeld E, Bentov Y, Burstein E, Friger M, Potashnik G. Impact of hypnosis during embryo transfer on the outcome of in vitro fertilization-embryo transfer: a case-control study. Fertil Steril. 2006 May;85(5):1404-8. doi: 10.1016/j.fertnstert.2005.10.035. Epub 2006 Mar 29.

    PMID: 16566936BACKGROUND
  • Fanchin R, Righini C, de Ziegler D, Olivennes F, Ledee N, Frydman R. Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertil Steril. 2001 Jun;75(6):1136-40. doi: 10.1016/s0015-0282(01)01787-3.

    PMID: 11384639BACKGROUND
  • Fanchin R, Righini C, Olivennes F, Taylor S, de Ziegler D, Frydman R. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod. 1998 Jul;13(7):1968-74. doi: 10.1093/humrep/13.7.1968.

    PMID: 9740459BACKGROUND
  • Zhu L, Che HS, Xiao L, Li YP. Uterine peristalsis before embryo transfer affects the chance of clinical pregnancy in fresh and frozen-thawed embryo transfer cycles. Hum Reprod. 2014 Jun;29(6):1238-43. doi: 10.1093/humrep/deu058. Epub 2014 Mar 23.

    PMID: 24664129BACKGROUND
  • Boivin J, Takefman JE. Stress level across stages of in vitro fertilization in subsequently pregnant and nonpregnant women. Fertil Steril. 1995 Oct;64(4):802-10. doi: 10.1016/s0015-0282(16)57858-3.

    PMID: 7672154BACKGROUND
  • Csemiczky G, Landgren BM, Collins A. The influence of stress and state anxiety on the outcome of IVF-treatment: psychological and endocrinological assessment of Swedish women entering IVF-treatment. Acta Obstet Gynecol Scand. 2000 Feb;79(2):113-8. doi: 10.1034/j.1600-0412.2000.079002113.x.

    PMID: 10696958BACKGROUND
  • Eugster A, Vingerhoets AJ, van Heck GL, Merkus JM. The effect of episodic anxiety on an in vitro fertilization and intracytoplasmic sperm injection treatment outcome: a pilot study. J Psychosom Obstet Gynaecol. 2004 Mar;25(1):57-65. doi: 10.1080/01674820410001737441.

    PMID: 15376405BACKGROUND
  • Friedler S, Glasser S, Azani L, Freedman LS, Raziel A, Strassburger D, Ron-El R, Lerner-Geva L. The effect of medical clowning on pregnancy rates after in vitro fertilization and embryo transfer. Fertil Steril. 2011 May;95(6):2127-30. doi: 10.1016/j.fertnstert.2010.12.016. Epub 2011 Jan 6.

    PMID: 21211796BACKGROUND
  • Manheimer E, van der Windt D, Cheng K, Stafford K, Liu J, Tierney J, Lao L, Berman BM, Langenberg P, Bouter LM. The effects of acupuncture on rates of clinical pregnancy among women undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2013 Nov-Dec;19(6):696-713. doi: 10.1093/humupd/dmt026. Epub 2013 Jun 27.

    PMID: 23814102BACKGROUND
  • Qian Y, Xia XR, Ochin H, Huang C, Gao C, Gao L, Cui YG, Liu JY, Meng Y. Therapeutic effect of acupuncture on the outcomes of in vitro fertilization: a systematic review and meta-analysis. Arch Gynecol Obstet. 2017 Mar;295(3):543-558. doi: 10.1007/s00404-016-4255-y. Epub 2016 Dec 19.

    PMID: 27995371BACKGROUND
  • Wang X, Lin H, Chen M, Wang J, Jin Y. Effect of acupuncture on in vitro fertilization: An updated systematic review and data mining protocol. Medicine (Baltimore). 2018 Jun;97(24):e10998. doi: 10.1097/MD.0000000000010998.

    PMID: 29901590BACKGROUND
  • Villahermosa DI, Santos LG, Nogueira MB, Vilarino FL, Barbosa CP. Influence of acupuncture on the outcomes of in vitro fertilisation when embryo implantation has failed: a prospective randomised controlled clinical trial. Acupunct Med. 2013 Jun;31(2):157-61. doi: 10.1136/acupmed-2012-010269. Epub 2013 Mar 19.

    PMID: 23512550BACKGROUND
  • Spielberger CD. Manual for the State-Trait Anxiety Inventory: STAI (form Y). Palo Alto, CA: Consulting Psychologists Press. 1983.

    BACKGROUND
  • Murphy EM, Nichols J, Somkuti SG, Sobel M, Braverman A, Barmat LI. Randomized trial of harp therapy during in vitro fertilization-embryo transfer. J Evid Based Complementary Altern Med. 2014 Apr;19(2):93-8. doi: 10.1177/2156587213514054. Epub 2013 Dec 18.

    PMID: 24668261BACKGROUND
  • Cheung C, Saravelos SH, Chan T, Sahota DS, Wang CC, Chung PW, Li TC. A prospective observational study on the stress levels at the time of embryo transfer and pregnancy testing following in vitro fertilisation treatment: a comparison between women with different treatment outcomes. BJOG. 2019 Jan;126(2):271-279. doi: 10.1111/1471-0528.15434. Epub 2018 Sep 25.

    PMID: 30106234BACKGROUND
  • Saravelos SH, Wong AW, Kong GW, Huang J, Klitzman R, Li TC. Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles. J Obstet Gynaecol Res. 2016 Jun;42(6):684-93. doi: 10.1111/jog.12962. Epub 2016 Feb 24.

    PMID: 26916559BACKGROUND
  • McKay KA, Buen JE, Bohan KJ, Maye JP. Determining the relationship of acute stress, anxiety, and salivary alpha-amylase level with performance of student nurse anesthetists during human-based anesthesia simulator training. AANA J. 2010 Aug;78(4):301-9.

    PMID: 20879631BACKGROUND
  • Aba YA, Avci D, Guzel Y, Ozcelik SK, Gurtekin B. Effect of music therapy on the anxiety levels and pregnancy rate of women undergoing in vitro fertilization-embryo transfer: A randomized controlled trial. Appl Nurs Res. 2017 Aug;36:19-24. doi: 10.1016/j.apnr.2017.05.005. Epub 2017 May 22.

    PMID: 28720234BACKGROUND
  • Okhowat J, Murtinger M, Schuff M, Wogatzky J, Spitzer D, Vanderzwalmen P, Wirleitner B, Zech NH. Massage therapy improves in vitro fertilization outcome in patients undergoing blastocyst transfer in a cryo-cycle. Altern Ther Health Med. 2015 Mar-Apr;21(2):16-22.

    PMID: 25830275BACKGROUND
  • Mahrer NE, Gold JI. The use of virtual reality for pain control: a review. Curr Pain Headache Rep. 2009 Apr;13(2):100-9. doi: 10.1007/s11916-009-0019-8.

    PMID: 19272275BACKGROUND
  • Li A, Montano Z, Chen VJ, Gold JI. Virtual reality and pain management: current trends and future directions. Pain Manag. 2011 Mar;1(2):147-157. doi: 10.2217/pmt.10.15.

    PMID: 21779307BACKGROUND
  • Niharika P, Reddy NV, Srujana P, Srikanth K, Daneswari V, Geetha KS. Effects of distraction using virtual reality technology on pain perception and anxiety levels in children during pulp therapy of primary molars. J Indian Soc Pedod Prev Dent. 2018 Oct-Dec;36(4):364-369. doi: 10.4103/JISPPD.JISPPD_1158_17.

    PMID: 30324926BACKGROUND
  • Garrett B, Taverner T, Gromala D, Tao G, Cordingley E, Sun C. Virtual Reality Clinical Research: Promises and Challenges. JMIR Serious Games. 2018 Oct 17;6(4):e10839. doi: 10.2196/10839.

    PMID: 30333096BACKGROUND
  • Dascal J, Reid M, IsHak WW, Spiegel B, Recacho J, Rosen B, Danovitch I. Virtual Reality and Medical Inpatients: A Systematic Review of Randomized, Controlled Trials. Innov Clin Neurosci. 2017 Feb 1;14(1-2):14-21. eCollection 2017 Jan-Feb.

    PMID: 28386517BACKGROUND
  • Gershon J, Zimand E, Lemos R, Rothbaum BO, Hodges L. Use of virtual reality as a distractor for painful procedures in a patient with pediatric cancer: a case study. Cyberpsychol Behav. 2003 Dec;6(6):657-61. doi: 10.1089/109493103322725450.

    PMID: 14756933BACKGROUND
  • Tarrant J, Viczko J, Cope H. Virtual Reality for Anxiety Reduction Demonstrated by Quantitative EEG: A Pilot Study. Front Psychol. 2018 Jul 24;9:1280. doi: 10.3389/fpsyg.2018.01280. eCollection 2018.

    PMID: 30087642BACKGROUND
  • Patterson DR, Tininenko JR, Schmidt AE, Sharar SR. Virtual reality hypnosis: a case report. Int J Clin Exp Hypn. 2004 Jan;52(1):27-38. doi: 10.1076/iceh.52.1.27.23925.

    PMID: 14768967BACKGROUND

Study Officials

  • Clifford Librach, MD

    CReATe Fertility Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
The Physician performing the embryo transfer will be blinded to the patient's group randomization
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clifford Librach, MD, FRCS(C), FACOG(REI), Director of the Create Fertility Centre, Professor, Department of Obstetrics and Gynecology, University of Toronto

Study Record Dates

First Submitted

May 6, 2020

First Posted

May 20, 2020

Study Start

May 31, 2019

Primary Completion

August 1, 2023

Study Completion

August 1, 2023

Last Updated

March 7, 2024

Record last verified: 2024-03

Locations